Interface Biologics Appoints Art Rosenthal to Chairman of its Board of Directors
February 14, 2011 08:31 ET
|
Interface Biologics Inc.
TORONTO, ONTARIO--(Marketwire - Feb. 14, 2011) - Interface Biologics Inc. (IBI), a privately held commercial stage developer of transformative biomedical-polymer products, is pleased...
Interface Biologics Announces $7M Financing
January 10, 2011 08:01 ET
|
Interface Biologics Inc.
TORONTO, CANADA--(Marketwire - Jan. 10, 2011) - Interface Biologics Inc. (IBI), a privately held commercial stage developer of transformative biomedical-polymer products, is pleased...